Cellex Cell Professionals GmbH
Overview
Cellex Cell Professionals is a Germany-based contract development and manufacturing organization (CDMO) with over 10 years of experience in autologous and allogeneic cell and gene therapy (CGT) products. The company supports partners from preclinical development through to commercialization and is involved in the manufacturing of several commercial CAR-T therapies. Its services include cell collection, supply chain management, logistics, and consulting on GMP processes. Cellex was a founding partner in the 2021 launch of AvenCell Therapeutics, a CAR T-cell therapy company, to which it contributed its switchable universal CAR-T technology and manufacturing expertise.
Portfolio Companies
1
Website
cellex.meInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| AvenCell | Jun 2021 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Cellex Cell Professionals GmbH based?
Cellex Cell Professionals GmbH is headquartered in Germany.
When was Cellex Cell Professionals GmbH founded?
Founding year information for Cellex Cell Professionals GmbH is not publicly available.
How many portfolio companies does Cellex Cell Professionals GmbH have?
Cellex Cell Professionals GmbH has 1 portfolio company in Caplight's dataset.
What are some companies in Cellex Cell Professionals GmbH's portfolio?
Portfolio companies visible on Caplight include AvenCell.
What was Cellex Cell Professionals GmbH's most recent investment shown here?
Cellex Cell Professionals GmbH's most recent investment in this portfolio sample was in AvenCell in 2021.
What sectors does Cellex Cell Professionals GmbH focus on?
Cellex Cell Professionals GmbH focuses on Healthcare & Life Sciences.
What company stages does Cellex Cell Professionals GmbH focus on?
Cellex Cell Professionals GmbH typically invests at the Early stage.